Treatment of hepatocellular carcinoma.
Nicoli
N
N
Institute of Clinical Surgery, University of Verona, Italy.
Marchiori
L
L
Mansueto
G C
GC
Morana
G
G
Bellini
A
A
Musajo
F
F
Bortolasi
L
L
Dal Dosso
I
I
Costa
V
V
Pederzoli
P
P
D000081:Acetamides / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000601:surgery / Q000628:therapy*; D002404:Catheterization; D016461:Chemoembolization, Therapeutic; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D006498:Hepatectomy / Q000379:methods; D006499:Hepatic Artery; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage; D015996:Survival Rate
D000081:Acetamides; D008937:Mitomycins; C081524:N,N'-diacetyl-1,6-diaminohexane; D007459:Iodized Oil